ISRCTN54178182已完成不适用
A randomised trial of chemotherapy and radiotherapy versus radiotherapy alone as adjuvant treatment in women with node positive operable cancer of the cervix
Medical Research Council (MRC) (UK)0 个研究点目标入组 1,000 人开始时间: 2000年4月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically confirmed cancer of the cervix with: Squamous, adenosquamous or adencarcinoma cell type/International Federation of Gynecology and Obstetrics (FIGO) stage IB or IIA/Nodal involvement (of any extent)
- •2. Patient fit to receive, and with no contraindication to, cisplatin-based chemotherapy
- •3. Patient should have undergone a radical hysterectomy, a pelvic lymphadenectomy and resection of any suspicious (enlarged) common iliac or para-aortic lymph nodes where appropriate
- •4. No concomitant or previous malignancy likely to interfere with protocol treatments or comparisons
- •5. Written informed consent
排除标准
- •1. WBC less than 3.5 x 10 to the power of 9 per litre
- •2. Platelets less than 100 x 10 to the power of 9 per litre
- •3. Bilirubin more than 1.25 times the upper limit of normal
- •4. Glomerular filtration rate less than 50 millilitres per minute
- •5. Uncontrolled or potentially active site of infection (eg fistula or abscesses)
研究者
相似试验
已完成
3 期
A randomized trial of chemoradiotherapy and chemotherapy for locally advanced pancreatic cancerpancreatic cancerJPRN-UMIN000001923Department of Surgical Oncology and HBP Surgery, Kagoshima University Graduate School100
招募中
不适用
Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinomaocally advanced head and neck squamous cell carcinomaJPRN-UMIN000021841Yokohama City University hospital50
进行中（未招募）
不适用
Strain sUrveillance during Chemotherapy for improving Cardiovascular OUtcomesACTRN12614000341628Menzies Research Institute Tasmania331
尚未招募
2 期
A randomised phase II study of radio-chemotherapy with or without panitumumab (Vectibix®) in irresectable squamous cell carcinoma or adenocarcinoma of the oesophagus (Panoramic)NL-OMON34246niversitair Medisch Centrum Sint Radboud124
进行中（未招募）
1 期
A randomised phase II study of radio-chemotherapy with or without panitumumab (Vectibix®) in irresectable squamous cell carcinoma or adenocarcinoma of the oesophagus (Panoramic) - PANORAMIChistology proven irresectable squamous cell or adenocarcinoma of the oesophagusMedDRA version: 12.1Level: LLTClassification code 10055476Term: Esophageal squamous cell carcinomaMedDRA version: 12.1Level: LLTClassification code 10055458Term: Esophageal adenocarcinomaEUCTR2010-019595-79-NLniversity Medical Centre Nijmegen124